|
Market Closed -
Australian S.E.
02:27:07 22/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.2400 AUD | -4.00% |
|
-2.04% | -28.36% |
| 08-25 | Compumedics Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-25 | Compumedics Fiscal 2026 EBITDA, Revenue Up | MT |
Company Valuation: Compumedics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 59.35 | 48.97 | 50.94 | 49.94 | - | - |
| Change | - | -17.49% | 4.02% | -1.96% | - | - |
| Enterprise Value (EV) | 59.35 | 48.97 | 50.94 | 49.94 | 49.94 | 49.94 |
| Change | - | -17.49% | 4.02% | -1.96% | 0% | 0% |
| P/E | -335x | -36.4x | 255x | 11.9x | 7.81x | 5.68x |
| PBR | - | - | - | - | - | - |
| PEG | - | -0x | -2x | 0x | 0.1x | 0.2x |
| Capitalization / Revenue | - | 0.96x | 0.85x | 0.66x | 0.55x | 0.45x |
| EV / Revenue | - | 0x | 0x | 0.66x | 0.55x | 0.45x |
| EV / EBITDA | - | 0x | 0x | 5.55x | 4.09x | 3.18x |
| EV / EBIT | - | 0x | 0x | 7.68x | 5.2x | 3.84x |
| EV / FCF | - | -0x | 0x | 15.6x | 8.92x | 7.03x |
| FCF Yield | - | -13.7% | 5.3% | 6.41% | 11.2% | 14.2% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.001 | -0.007 | 0.001 | 0.021 | 0.032 | 0.044 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 50.96 | 60.25 | 75.6 | 91 | 112 |
| EBITDA 1 | - | 2.938 | 3.985 | 9 | 12.2 | 15.7 |
| EBIT 1 | - | 0.692 | 1.787 | 6.5 | 9.6 | 13 |
| Net income 1 | -0.499 | -1.272 | 0.214 | 6 | 9.2 | 12.5 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 0.3350 | 0.2550 | 0.2550 | 0.2500 | 0.2500 | 0.2500 |
| Nbr of stocks (in thousands) | 177,163 | 192,039 | 199,762 | 199,762 | - | - |
| Announcement Date | 8/30/24 A | 8/26/25 A | 8/24/26 A | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 11.9x | - | - | - | 35.09M | |
| 34.82x | 6.04x | 22.98x | 0.27% | 257B | |
| 38.73x | 7.03x | 22.12x | 0.62% | 164B | |
| 48.33x | 12.15x | 26.17x | -.--% | 151B | |
| 16.73x | 3.35x | 10.93x | -.--% | 64.51B | |
| 20.43x | 2.45x | 12.38x | 2.47% | 52.1B | |
| 49.08x | 12.15x | 26.78x | -.--% | 51.9B | |
| 35.55x | 7x | 22.21x | -.--% | 50.95B | |
| 34.63x | 6.86x | 23.34x | 0.58% | 50.11B | |
| 80.08x | 7.62x | 23.13x | -.--% | 44.95B | |
| Average | 37.03x | 7.18x | 21.11x | 0.44% | 88.68B | |
| Weighted average by Cap. | 38.85x | 7.40x | 22.07x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CMP Stock
- Valuation Compumedics Limited
Select your edition
All financial news and data tailored to specific country editions
